Search by keywords: Upcoming Seminars and Events View upcoming seminars and events. Learn more 554 News Items found Q&A 3D Shape of an Ion Channel Revealed Wednesday, February 8, 2012 Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1. In the News Memorial Sloan Kettering Made Major Contributions to Cancer Advances in 2011 Monday, February 6, 2012 Two of the year's top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators. In the Lab Researchers Shed Light on Possible Cause of Infections in Cancer Patients Friday, January 20, 2012 Infections are a common cause of complications in cancer patients. Now a Memorial Sloan Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection. In the Clinic Bone Scan Index May Help Determine Response to Prostate Cancer Treatment Friday, January 13, 2012 Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy. Honors Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Melanoma “Dream Team” Wednesday, December 14, 2011 Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma. In the Lab Findings Could Lead to the Development of a New Painkiller Tuesday, December 13, 2011 Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers. In the Lab Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy Friday, December 2, 2011 Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor. Profile Genetic Causes of Blood Cancers Explored Thursday, December 1, 2011 German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma. Out of the Lab and into the World: Hsp90 Inhibitor, a New Cancer Drug Thursday, December 1, 2011 A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer. Feature Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients Thursday, December 1, 2011 Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments. Pagination Load More